Early Post-RP Complications Directly Related to Age
The risk of virtually all early postoperative complications increases with increasing patient age at radical prostatectomy for localized prostate cancer.
The risk of virtually all early postoperative complications increases with increasing patient age at radical prostatectomy for localized prostate cancer.
Researchers sought to determine the effect of radical prostatectomy vs watchful waiting on life expectancy in men with prostate cancer.
The addition of mitoxantrone and prednisone (MP) to adjuvant androgen-deprivation therapy did not increase survival among patients with high-risk prostate cancer.
A meta-analysis of 11 studies revealed the effects of smoking outcomes of primary radical radiotherapy or radical prostatectomy for prostate cancer.
Propensity score-matched study compared adjuvant radiotherapy with surveillance and early-salvage radiotherapy after prostatectomy in men with prostate cancer.
QoL after radical prostatectomy, EBRT, or brachytherapy vs active surveillance for prostate cancer are similar.
A phase 3 study presented at the 2017 Genitourinary Cancers Symposium demonstrated the feasibility of conducting adjuvant trials.
Both insufficiency and deficiency of serum vitamin D correlated with an increased risk of unfavorable pathology in men undergoing radical prostatectomy for prostate cancer.
Older black men with localized prostate cancer were more likely to have poorer quality care, incur higher costs, and have worse postoperative outcomes than white men. However, that did not translate to worse overall or cancer-specific survival.
A recent study indicates a high rate of clinical upgrading at prostatectomy, based on over ten thousand patients reviewed.